ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at
the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay …

Despite major advances over the past decade, prevention and treatment of type 1 diabetes
mellitus (T1DM) remain suboptimal, with large and unexplained variations in individual …

Background An increased prevalence of diabetic ketoacidosis at diagnosis of type 1
diabetes in children was observed in various diabetes centres worldwide during the COVID …

First envisioned by early diabetes clinicians, a person-centred approach to care was an
aspirational goal that aimed to match insulin therapy to each individual's unique …

5 Bolland MJ. Vitamin D supplementation to prevent acute respiratory tract infections:
systematic review and meta-analysis of individual participant data. September, 2022 …

Abstract Type 1 diabetes (T1D) is a complex, chronic autoimmune disease that affects over
1.6 million people in the United States. It is now understood that T1D may be undetected for …

Aim To provide guidance for follow‐up and monitoring of children and adolescents identified
as positive to islet autoantibodies (IA) in the general population screening for type 1 …

Type 1 diabetes treatment stands at a crucial and exciting crossroad since the 2022 US
Food and Drug Administration approval of teplizumab to delay disease development. In this …

A diagnosis of type 1 diabetes (T1D) and the subsequent requirement for exogenous insulin
treatment is associated with considerable acute and chronic morbidity and a substantial …